Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Price: $0.39 | Change: +$0.005 | %Change: +1.30%
Volume: 32,725 | Day High/Low: 0.39/0.37 | 52 Week High/Low: 0.65/0.23
View modes: 
0 stars

RE:Pooya Hemami used to be the analyst at Desjardins covering

original source How to Bargain Hunt for Hot Biotechs: Edison's Pooya Hemami Source: Peter Byrne of The Life Sciences Report  (10/15/14) Every business day, Edison Investment Research Analyst Pooya...read more
0 stars

After six weeks of selling Egrifta again

The PPS has gone from 59 cents to 37.5 cents in six weeks.  I hope it is not an indication of how well the selling is going.  rate and reply
5 stars

RE:Euro Pacific Raise Price Target to $1 and rating to Spec Buy

Same guy who had a 12$ target price for TH while he was at Versant Partners couple years ago Lolllllll This company has the worst management team around...and by far! Never again...  rate and reply
5 stars

Euro Pacific Raise Price Target to $1 and rating to Spec Buy

Euro Pacific analyst Doug Loe has come out with a new report that raises the price target to $1 and the rating to speculative buy.  rate and reply
0 stars

Pooya Hemami used to be the analyst at Desjardins covering

TH -used to be very bullish on the stock.Interesting to note hat he owns the stock personnally http://internet.itbusinessnet.com/article/How-to-Bargain-Hunt-for-Hot-Biotechs:-Edisons-Pooya-Hemami...read more
0 stars

RE:RE:RE:RE:1 analyst

As you wrote before, proof is in the pudding. We'll get a good idea by February or if by any luck management releases numbers earlier.  rate and reply
0 stars

RE:RE:RE:1 analyst

ecstatic I am not...the only thing that will make me ecstatic is a rising share price based on fabulous results and new marketing approvals .......30% price increase on no sales does no increase the...read more
0 stars

RE:RE:1 analyst

Canada is a much larger market than Israel, and it is barely relevant. You will almost certainly find the price increase to be a wonderful thing in all subsequent quarterly reports. In fact, it will...read more
0 stars

RE:RE:1 analyst

I am not sure if price was the main issue why peak sales only made it up to 1300 patients.  If it wasn't then the extra 30% in revenue would be nice.  Tanguay said that sales are going as expected...read more
0 stars

RE:1 analyst

why did we find out just as a passing comment that Israel had refused the application...Not MATERIAL tANGUAY SAID....But when Canada approved they made a big fuss....Is Canada s market more important...read more
0 stars

1 analyst

With 2 stupid questions on the CC. How about opening the CC up to share holders??  rate and reply
0 stars

RE:RE:RE:RE:Wednesday

Thr burn rate in the quarter eas about 4 million dollars excluding the tax settlement The upfront mktg expenses are more than I expected the silver lining in the report is the statement that sales are...read more
0 stars

RE:RE:RE:Wednesday

A few points: 1.) There will be no sales in the quarterly report released tomorrow since they did not start selling until a couple weeks after the quarter ended. 2.) If the numbers they produced in...read more
0 stars

RE:RE:Wednesday

The should have about $6 to $7 million left as of Aug 31.  So if sales are not good then dillutive financing would be a possiblity.  I am just wondering why people are selling now.  Do they actually...read more
0 stars

RE:Wednesday

not sure you can assume that bad news is coming ...trading volumes are not large and the stock market in general has been quite weak in recent weeks. My short term worry is dilutive financing ........  rate and reply
0 stars

Wednesday

The the price action in mind over the last week should be worried about any bad news coming on Wednesday?  Any thoughts...  rate and reply
0 stars

RE:RE:RE:RE:You need to check out the new TH Corpoate Presentation

None. You have to figure there is at least a little channel filling going on that might help initial sales. But, unless the company decides to tell us sooner, we may not hear anything truly meaningful...read more
0 stars

RE:RE:RE:RE:RE:You need to check out the new TH Corpoate Presentation

You are right, if they execute on US sales, they will have a much higher PE and a much higher share price. As for a dilutive financing, there really is no reason for that at this point. I am guessing...read more
0 stars

RE:RE:RE:RE:You need to check out the new TH Corpoate Presentation

Ifthey achieve 17 cents EPS and growing sales from that base the PE will be way over 10.....but for now it is all forward looking from zero sales until maybe 2 or 3 weeks ago The presentation also...read more
0 stars

RE:RE:RE:You need to check out the new TH Corpoate Presentation

I just divided 9.3 by 61 and then by .9 to get Canadian $. Because the share price is in Canadian $. That comes to 17 cents. If you multiply that by 10 you'd get $1.70/share. About 3x what we are...read more